No Picture
News

Therapeutic Solutions International Launches Campbell Neurosciences Inc as First Suicide Focused Regenerative Psychiatry Biotechnology Company

Campbell Neurosciences to License Key Intellectual Property Assets as Clinical Trials of Campbell Score and Kaihani Score are Ongoing

OCEANSIDE, Calif., Dec. 31, 2020 /PRNewswire/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), ann… […]

No Picture
News

Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology

– Horizon to use ENHANZE® subcutaneous delivery technology for TEPEZZA® (teprotumumab-trbw) –

DUBLIN and SAN DIEGO, Nov. 23, 2020 /PRNewswire/ — Horizon Therapeutics plc (Nasdaq:  HZNP) and Halozyme Therapeutics, Inc. (Nasdaq:  HALO) today announce… […]

No Picture
News

Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19

Partnership Leverages TScan’s Proprietary High-throughput TCR/Target Discovery Platform and Poseida’s Proprietary Allogeneic T Cell Approach to Advance Potential TCR-T Treatments

SAN DIEGO and WALTHAM, Mass., Oct. 21, 2020 /PRNewswire/ — Poseida The… […]

No Picture
News

Qualigen Therapeutics Enters into Commercialization Agreement for its FastPack® Diagnostic Products in China

Yi Xin Zhen Duan Jishu will develop new generations of FastPack-based diagnostic systems while manufacturing and selling current products

CARLSBAD, Calif., Oct. 8, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces it has enter… […]

No Picture
News

Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology

SAN DIEGO, Oct. 6, 2020 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Halozyme and argenx are expanding their existing global collaboration and license agreement that was signed in February 2019.
Under the newly ann… […]

No Picture
News

Ionis and Genuity Science announce agreement designed to rapidly translate genomic insights into therapeutics

Multi-year collaboration is expected to generate genetically validated targets for up to 20 diseases

BOSTON and CARLSBAD, Calif., Oct. 1, 2020 /PRNewswire/ — Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDA… […]

No Picture
News

Coastal Health USA Selects 3M(TM) Clean-Trace(TM) for Environmental Data Gathering for Their Infection Control Planning Services

Provides auditing and maintenance data for reporting on the effectiveness and health of antimicrobial technology

SAN DIEGO, Aug. 25, 2020 /PRNewswire/ — Coastal Health USA and 3M unite to provide businesses with Adenosine Triphosphate (ATP) monitori… […]

No Picture
News

HUYA Bioscience International Licenses the Novel SHP2 Inhibitor HBI-2376 for Development in Oncology

 SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — HUYA Bioscience International (HUYABIO

®
), the leader in accelerating global development of China’s pharmaceutical innovations, announced today it has exclusively licensed worldwide rights, … […]

No Picture
News

Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva

— Test gives simple positive or negative color change results in 30 minutes or less– No special laboratory equipment required, hence practical for on-site deployment– Test uses saliva, eliminating need for painful nasal swabbing– Study shows sensit… […]